TherapeuticsMD (TXMD) Depreciation & Amortization (IS): 2011-2025
Historic Depreciation & Amortization (IS) for TherapeuticsMD (TXMD) over the last 10 years, with Sep 2025 value amounting to $96,000.
- TherapeuticsMD's Depreciation & Amortization (IS) changed negligibly% to $96,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $387,000, marking a year-over-year decrease of 63.00%. This contributed to the annual value of $509,000 for FY2024, which is 44.79% down from last year.
- Latest data reveals that TherapeuticsMD reported Depreciation & Amortization (IS) of $96,000 as of Q3 2025, which was down 0.00% from $96,000 recorded in Q2 2025.
- In the past 5 years, TherapeuticsMD's Depreciation & Amortization (IS) registered a high of $637,000 during Q4 2023, and its lowest value of $27,000 during Q1 2023.
- Moreover, its 3-year median value for Depreciation & Amortization (IS) was $100,000 (2024), whereas its average is $156,182.
- Over the last 5 years, TherapeuticsMD's Depreciation & Amortization (IS) had its largest YoY gain of 392.59% in 2024, and its largest YoY loss of 84.30% in 2024.
- Quarterly analysis of 3 years shows TherapeuticsMD's Depreciation & Amortization (IS) stood at $637,000 in 2023, then slumped by 84.30% to $100,000 in 2024, then remained steady at $96,000 in 2025.
- Its Depreciation & Amortization (IS) stands at $96,000 for Q3 2025, versus $96,000 for Q2 2025 and $95,000 for Q1 2025.